|
1
|
Jemal A, Siegel R, Xu J and Ward E: Cancer
statistics, 2010. CA Cancer J Clin. 60:277–300. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Qiu X, Liang Y, Sellers RS, Perez-Soler R
and Zou Y: Aerosol azacytidine inhibits orthotopic lung cancers in
mice through Its DNA demethylation and gene reactivation effects.
PLoS One. 9:e1098742014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Goldstraw P, Crowley J, Chansky K, Giroux
DJ, Groome PA, Rami-Porta R, Postmus PE, Rusch V and Sobin L:
International Association for the Study of Lung Cancer
International Staging Committee; Participating Institutions: The
IASLC lung cancer staging project: Proposals for the revision of
the TNM stage groupings in the forthcoming (seventh) edition of the
TNM Classification of malignant tumours. J Thorac Oncol. 2:706–714.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Liutkevičiūtė Z, Kriukienė E, Ličytė J,
Rudytė M, Urbanavičiūtė G and Klimašauskas S: Direct
decarboxylation of 5-carboxylcytosine by DNA C5-methyltransferases.
J Am Chem Soc. 136:5884–5887. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Delhommeau F, Dupont S, Della Valle V,
James C, Trannoy S, Massé A, Kosmider O, Le Couedic JP, Robert F,
Alberdi A, et al: Mutation in TET2 in myeloid cancers. N Engl J
Med. 360:2289–2301. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wu H, Wu X, Shen L and Zhang Y:
Single-base resolution analysis of active DNA demethylation using
methylase-assisted bisulfite sequencing. Nat Biotechnol.
32:1231–1240. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li Y, Córdoba-Cañero D, Qian W, Zhu X,
Tang K, Zhang H, Ariza RR, Roldán-Arjona T and Zhu JK: An AP
endonuclease functions in active DNA dimethylation and gene
imprinting in Arabidopsis (corrected). PLoS Genet. 11:e10049052015.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Dong ZR, Zhang C, Cai JB, Zhang PF, Shi
GM, Gao DM, Sun HC, Qiu SJ, Zhou J, Ke AW and Fan J: Role of
5-hydroxymethylcytosine level in diagnosis and prognosis prediction
of intrahepatic cholangiocarcinoma. Tumour Biol. 36:2763–2771.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kudo Y, Tateishi K, Yamamoto K, Yamamoto
S, Asaoka Y, Ijichi H, Nagae G, Yoshida H, Aburatani H and Koike K:
Loss of 5-hydroxymethylcytosine is accompanied with malignant
cellular transformation. Cancer Sci. 103:670–676. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Gu J, Ding JY, Lu CL, Lin ZW, Chu YW, Zhao
GY, Guo J and Ge D: Overexpression of CD88 predicts poor prognosis
in non-small-cell lung cancer. Lung Cancer. 81:259–265. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sica GL and Gal AA: Lung cancer staging:
Pathology issues. Semin Diagn Pathol. 29:116–126. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Travis WD, Brambilla E, Nicholson AG,
Yatabe Y, Austin JH, Beasley MB, Chirieac LR, Dacic S, Duhig E,
Flieder DB, et al: WHO Panel: The 2015 World Health Organization
Classification of Lung Tumors: Impact of Genetic, Clinical and
Radiologic Advances Since the 2004 Classification. J Thorac Oncol.
10:1243–1260. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ke AW, Shi GM, Zhou J, Huang XY, Shi YH,
Ding ZB, Wang XY, Devbhandari RP and Fan J: CD151 amplifies
signaling by integrin α6β1 to PI3K and induces the
epithelial-mesenchymal transition in HCC cells. Gastroenterology.
140:1629–1641.e15. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhao GY, Ding JY, Lu CL, Lin ZW and Guo J:
The overexpression of 14-3-3ζ and Hsp27 promotes non-small cell
lung cancer progression. Cancer. 120:652–663. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hattman S: The first recognized epigenetic
signal: DNA glucosylation of T-even bacteriopages. Epigenetics.
4:150–151. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yin R, Mo J, Lu M and Wang H: Detection of
human urinary 5-hydroxymethylcytosine by stable isotope dilution
HPLC-MS/MS analysis. Anal Chem. 87:1846–1852. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yang Q, Wu K, Ji M, Jin W, He N, Shi B and
Hou P: Decreased 5-hydroxymethylcytosine (5-hmC) is an independent
poor prognostic factor in gastric cancer patients. J Biomed
Nanotechnol. 9:1607–1616. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kriaucionis S and Heintz N: The nuclear
DNA base 5-hydroxymethylcytosine is present in Purkinje neurons and
the brain. Science. 324:929–930. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tahiliani M, Koh KP, Shen Y, Pastor WA,
Bandukwala H, Brudno Y, Agarwal S, Iyer LM, Liu DR, Aravind L and
Rao A: Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in
mammalian DNA by MLL partner TET1. Science. 324:930–935. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Moen EL, Mariani CJ, Zullow H, Jeff-Eke M,
Litwin E, Nikitas JN and Godley LA: New themes in the biological
functions of 5-methylcytosine and 5-hydroxymethylcytosine. Immunol
Rev. 263:36–49. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ye C and Li L: 5-hydroxymethylcytosine: A
new insight into epigenetics in cancer. Cancer Biol Ther. 15:10–15.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ulas A, Turkoz FP, Silay K, Tokluoglu S,
Avci N, Oksuzoglu B and Alkis N: A laboratory prognostic index
model for patients with advanced non-small cell lung cancer. PLoS
One. 9:e1144712014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Campobasso O, Andrion A, Mancuso M, De
Simone M and Ribotta M: The postoperative survival in pulmonary
carcinomas depending on the histological type and stage. Ann Osp
Maria Vittoria Torino. 31:9–24. 1989.(In Italian). PubMed/NCBI
|
